Aton (BST:3HB)

Germany · Delayed Price · Currency is EUR

0.0112

-0.0006 (-5.08%)

At close: Sep 18, 2026

Market Cap	9.94M +69.2%
Revenue (ttm)	661.00K +7.7%
Net Income	-962.00K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0118
Previous Close	0.0118
Day's Range	0.0112 - 0.0128
52-Week Range	0.0002 - 0.0258
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About Aton

Aton operates as a bioscience company in France. It engages in drug development, preclinical and clinical services, production of monoclonal antibodies, laboratory equipment production, and designing and manufacturing of medical devices, as well as provision of human tissues. The company also offers medical devices for surgeons, powered by Stemcis. The company was founded in 1998 and is headquartered in Strasbourg, France. [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 1998

Employees 13

Stock Exchange Stuttgart Stock Exchange

Ticker Symbol 3HB

Financial Performance

In 2025, Aton's revenue was 661,000, an increase of 7.65% compared to the previous year's 614,000. Losses were -962,000, -12.62% less than in 2024.

Financial Statements